Get the Stockscreener App
1.848
3.24%
0.058
After Hours:
1.81
-0.038
-2.06%
Ernexa Therapeutics Inc stock is traded at $1.848, with a volume of 72,933.
It is up +3.24% in the last 24 hours and down -0.11% over the past month.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
See More
Previous Close:
$1.79
Open:
$1.79
24h Volume:
72,933
Relative Volume:
1.03
Market Cap:
$13.60M
Revenue:
$598.00K
Net Income/Loss:
$-44.93M
P/E Ratio:
-0.2224
EPS:
-8.31
Net Cash Flow:
$-17.32M
1W Performance:
-16.38%
1M Performance:
-0.11%
6M Performance:
-66.38%
1Y Performance:
-93.18%
1-Day Range:
$1.7617
$1.87
1-Week Range:
$1.71
$2.57
52-Week Range:
$1.71
$29.25
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Name
Ernexa Therapeutics Inc
Sector
Industry
Phone
(617) 798-6700
Address
1035 CAMBRIDGE STREET, CAMBRIDGE
Compare ERNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.848 | 13.18M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc Stock (ERNA) Latest News
What MACD signals say about Ernexa Therapeutics Inc.Free Triple Return Setup with Risk Control - Newser
Using data models to predict Ernexa Therapeutics Inc. stock movementDaily Technical Chart Pattern Analysis Report - Newser
Why Ernexa Therapeutics Inc. stock attracts strong analyst attentionHigh Accuracy Alerts for ROI Traders Detected - metal.it
Will Ernexa Therapeutics Inc. stock benefit from AI tech trendsStock Entry Point Planner with Volume Spike - Newser
Why Ernexa Therapeutics Inc. stock is on top investor watchlistsShort-Term Market Movement Forecast Report - Newser
Published on: 2025-07-29 02:58:28 - Newser
How Ernexa Therapeutics Inc. stock performs during market volatilityFree Conservative Long Term Growth Plans - Newser
What are the latest earnings results for Ernexa Therapeutics Inc.Expert Picks Tips With High Returns - jammulinksnews.com
What is Ernexa Therapeutics Inc. company’s growth strategyChart Pattern Data Feed For Beginners - jammulinksnews.com
Is Ernexa Therapeutics Inc. Forming a Bottom PatternChart Breakout Buy Signal Detection Confirmed - metal.it
What are analysts’ price targets for Ernexa Therapeutics Inc. in the next 12 monthsHigh-yield investments - jammulinksnews.com
Is Ernexa Therapeutics Inc. a candidate for recovery playAI Enhanced Strategy for Portfolio Growth - Newser
What is the dividend policy of Ernexa Therapeutics Inc. stockInvest confidently with professional market insights - jammulinksnews.com
What makes Ernexa Therapeutics Inc. stock price move sharplyBreakthrough stock performance - jammulinksnews.com
How strong is Ernexa Therapeutics Inc. company’s balance sheetAchieve consistent profits with disciplined trading - jammulinksnews.com
Published on: 2025-07-27 21:08:51 - metal.it
What analysts say about Ernexa Therapeutics Inc. stockConsistently superior profits - PrintWeekIndia
Ernexa Therapeutics Inc. Stock Analysis and ForecastPhenomenal trading returns - PrintWeekIndia
How Ernexa Therapeutics Inc. stock reacts to Fed policy changesTremendous growth potential - jammulinksnews.com
Is Ernexa Therapeutics Inc. a good long term investmentBreakout portfolio performance - PrintWeekIndia
What drives Ernexa Therapeutics Inc. stock priceHigh-octane investment gains - jammulinksnews.com
how ernexa therapeutics inc. stock performs during market volatilityFree Access to Stock Community - Newser
Ernexa Therapeutics Inc Stock (ERNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):